121 related articles for article (PubMed ID: 3166276)
41. [Clinical experience of "urobiotic" for urinary infections].
Kusunoki T; Kasai M; Nagahara A
Hinyokika Kiyo; 1966 Apr; 12(4):415-8. PubMed ID: 6006493
[No Abstract] [Full Text] [Related]
42. [Urinary tract infections in outpatients treated in 2002-2003].
Luczak M; Rokosz A; Wachnik A; Kamola R; Stypułkowska A
Przegl Lek; 2005; 62(2):81-5. PubMed ID: 16095149
[TBL] [Abstract][Full Text] [Related]
43. [Clinical and fundamental studies on ceftriaxone (CTRX) against urinary tract infections].
Nishio S; Yoshihara H
Hinyokika Kiyo; 1988 May; 34(5):937-42. PubMed ID: 3177133
[TBL] [Abstract][Full Text] [Related]
44. [Clinical experiences with the new bactericidal broad-band chemotherapeutic drug co-tetroxazine].
Kertzendorff KW
Med Welt; 1980 Sep; 31(37):1321-5. PubMed ID: 7432127
[No Abstract] [Full Text] [Related]
45. [Clinical trial of ofloxacin (Tarivid R)].
Belovezhdov N; Angelova I; Talakova Ch
Vutr Boles; 1988; 27(3):67-71. PubMed ID: 3061178
[TBL] [Abstract][Full Text] [Related]
46. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
47. [A clinical evaluation of CS-807 in patients with urinary tract infections].
Nakajima K; Oshinoya Y; Uchibayashi T; Ohkawa M; Hisazumi H
Hinyokika Kiyo; 1988 Aug; 34(8):1515-8. PubMed ID: 3195413
[TBL] [Abstract][Full Text] [Related]
48. [Sulfamethizole versus pivmecillinam in urinary tract infections].
Frimodt-Møller N
Ugeskr Laeger; 2003 Nov; 165(45):4317; author reply 4317-8. PubMed ID: 14635336
[No Abstract] [Full Text] [Related]
49. A case of purple urine.
Mumoli N; Cei M
QJM; 2009 Feb; 102(2):147. PubMed ID: 18772150
[No Abstract] [Full Text] [Related]
50. [Recurrent urinary tract infections].
Tataranni G; Malacarne F; Scaramuzzo P
G Clin Med; 1988 Nov; 69(11):689-94. PubMed ID: 3243402
[No Abstract] [Full Text] [Related]
51. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections.
Metlay JP; Strom BL; Asch DA
J Antimicrob Chemother; 2003 Apr; 51(4):963-70. PubMed ID: 12654756
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic strategies involving antimicrobial treatment of the canine urinary tract.
Ling GV
J Am Vet Med Assoc; 1984 Nov; 185(10):1162-4. PubMed ID: 6392247
[No Abstract] [Full Text] [Related]
53. Bacteriological and clinical experiences with ofloxacin in urinary tract infections.
Fröhlich G; Stratmeyer R
Chemioterapia; 1987 Jun; 6(2 Suppl):525-6. PubMed ID: 3509489
[No Abstract] [Full Text] [Related]
54. [In vitro activity, serum, urine and prostatic adenoma concentrations of ofloxacin in urologic patients with complicated urinary tract infections].
Naber KG; Adam D; Wittenberger R; Bartosik-Wich B
Infection; 1986; 14 Suppl 1():S60-4. PubMed ID: 2420725
[TBL] [Abstract][Full Text] [Related]
55. [Clinical experience with the use of ofloxacin in infections of the upper and lower urinary tracts: demonstrations of the results of clinical trials].
Liudvig G
Antibiot Khimioter; 1996; 41(9):84-5. PubMed ID: 9005795
[TBL] [Abstract][Full Text] [Related]
56. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.
Rugendorff EW
Drugs; 1987; 34 Suppl 1():91-4. PubMed ID: 3481333
[TBL] [Abstract][Full Text] [Related]
57. 3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.
Raz R; Rozenfeld S
Antimicrob Agents Chemother; 1996 Sep; 40(9):2200-1. PubMed ID: 8878607
[No Abstract] [Full Text] [Related]
58. [Urinary tract infections of the cirrhotic patient].
Gómez J; Vilardell F; Casais L; Prats G
Rev Esp Enferm Apar Dig; 1979 Oct; 56(4):321-6. PubMed ID: 542695
[No Abstract] [Full Text] [Related]
59. A multicenter study on clinical efficacy of ofloxacin in respiratory and urinary tract infections.
Grassi GG
Infection; 1986; 14 Suppl 4():S300-2. PubMed ID: 3546149
[TBL] [Abstract][Full Text] [Related]
60. [Gyrase inhibitor in pneumology. Ofloxacin--a new broad spectrum antibiotic in acute and chronic respiratory tract infections].
Rubin AR
Prax Klin Pneumol; 1985 Oct; 39(10):360-1. PubMed ID: 2999748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
